Related Experiment Videos
[Thromboembolic complications in inflammatory bowel disease]
J F Suárez Crespo1, F Nogueras López, F J de Teresa Galván
1Servicio de Aparato Digestivo, Hospital Universitario Virgen de las Nieves, Granada.
Gastroenterologia Y Hepatologia
|April 1, 1997
Summary
Thromboembolic events in inflammatory bowel disease (IBD) are uncommon but serious, particularly in young individuals. This study reports on arterial and venous thromboembolism in IBD patients, highlighting complex underlying mechanisms.
Area of Science:
- Gastroenterology
- Hematology
- Vascular Medicine
Background:
- Inflammatory bowel disease (IBD) is associated with an increased risk of thromboembolic complications.
- These events, though infrequent, carry significant morbidity and mortality, especially in younger IBD patients.
- The precise etiopathogenesis remains complex and debated, involving potential coagulation and fibrinolysis alterations.
Observation:
- This study reports on seven IBD patients (five with Crohn's disease, two with ulcerative colitis) experiencing multiple thromboembolic episodes.
- Six arterial events were documented, including iliac, femoral, humeral-axillary, internal carotid, and superior mesenteric artery thrombosis.
- Three venous events occurred, involving the brachyocephalic-subclavian trunk, axillary vein, and iliac-femoral/pulmonary embolism.
Findings:
- IBD-associated thromboembolism can manifest as both arterial and venous thrombosis.
- Arterial thrombosis, while less common than venous events, presents a significant clinical challenge in this patient cohort.
- The occurrence of thromboembolism in IBD patients is not solely explained by known coagulation disorders.
Implications:
- Understanding the complex mechanisms of IBD-related thromboembolism is crucial for effective management.
- Early recognition and tailored prophylaxis strategies are essential to mitigate morbimortality.
- Further research into the specific prothrombotic pathways in IBD is warranted.